CDK11A

cyclin dependent kinase 11A, the group of Cyclin dependent kinases

Basic information

Region (hg38): 1:1702379-1724357

Previous symbols: [ "CDC2L3", "CDC2L2" ]

Links

ENSG00000008128NCBI:728642OMIM:116951HGNC:1730Uniprot:Q9UQ88AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CDK11A gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CDK11A gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
5
clinvar
5
missense
46
clinvar
2
clinvar
48
nonsense
0
start loss
0
frameshift
1
clinvar
1
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 47 7 0

Variants in CDK11A

This is a list of pathogenic ClinVar variants found in the CDK11A region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-1703482-A-G not specified Uncertain significance (Jun 02, 2024)3265407
1-1703487-G-A Likely benign (Mar 01, 2023)2638052
1-1703489-C-T Likely benign (Oct 01, 2023)2638053
1-1703490-G-C not specified Uncertain significance (Jan 22, 2024)3141462
1-1703515-C-G not specified Uncertain significance (Jan 09, 2024)3141461
1-1703521-C-T not specified Uncertain significance (Mar 14, 2023)2469375
1-1703522-G-A not specified Uncertain significance (Nov 29, 2023)3141459
1-1703528-G-A not specified Uncertain significance (Jan 29, 2024)3141458
1-1703608-CT-C not provided (-)1810316
1-1703882-G-A not specified Uncertain significance (Dec 22, 2023)3141457
1-1703906-C-G not specified Uncertain significance (Jun 13, 2024)3265410
1-1703917-C-G not specified Uncertain significance (Jan 02, 2024)3141456
1-1704062-G-C not specified Uncertain significance (Dec 19, 2022)2337185
1-1704065-C-T not specified Uncertain significance (Sep 17, 2021)2251824
1-1704068-G-A not specified Uncertain significance (May 31, 2023)2554715
1-1704076-T-A Likely benign (Feb 01, 2023)2638054
1-1704094-G-C not specified Uncertain significance (Apr 26, 2024)3265405
1-1704112-G-T not specified Uncertain significance (Oct 12, 2022)2227540
1-1704124-C-T not specified Uncertain significance (May 24, 2023)2524988
1-1704133-C-T not specified Uncertain significance (Feb 07, 2023)2468748
1-1704135-A-G Likely benign (Nov 01, 2022)2638055
1-1704138-A-G Likely benign (Nov 01, 2022)2638056
1-1704238-G-A Likely benign (Jan 01, 2023)2638057
1-1704272-C-T not specified Uncertain significance (Jan 25, 2023)2479151
1-1704291-C-T not specified Uncertain significance (Apr 29, 2022)2206824

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CDK11Aprotein_codingprotein_codingENST00000404249 1921598
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.38e-170.011212405445831246410.00236
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.8283392991.130.00001885028
Missense in Polyphen5463.9280.84471211
Synonymous-3.121631201.360.000007911336
Loss of Function0.3162728.80.9360.00000155525

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001250.00125
Ashkenazi Jewish0.000.00
East Asian0.0002240.000223
Finnish0.01230.0121
European (Non-Finnish)0.001970.00189
Middle Eastern0.0002240.000223
South Asian0.002060.00196
Other0.002910.00281

dbNSFP

Source: dbNSFP

Function
FUNCTION: Appears to play multiple roles in cell cycle progression, cytokinesis and apoptosis. The p110 isoforms have been suggested to be involved in pre-mRNA splicing, potentially by phosphorylating the splicing protein SFRS7. The p58 isoform may act as a negative regulator of normal cell cycle progression. {ECO:0000269|PubMed:12501247, ECO:0000269|PubMed:12624090}.;
Pathway
terminal <i>O</i>-glycans residues modification;Recruitment of mitotic centrosome proteins and complexes;Centrosome maturation;G2/M Transition;Mitotic G2-G2/M phases;Cell Cycle;Cell Cycle, Mitotic (Consensus)

Recessive Scores

pRec
0.141

Haploinsufficiency Scores

pHI
hipred
N
hipred_score
0.370
ghis
0.519

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.781

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Gene ontology

Biological process
mitotic cell cycle;regulation of cell growth;regulation of transcription, DNA-templated;protein phosphorylation;apoptotic process;regulation of mRNA processing;regulation of cell cycle
Cellular component
nucleus;cytoplasm
Molecular function
protein kinase activity;protein serine/threonine kinase activity;cyclin-dependent protein serine/threonine kinase activity;ATP binding